Morgan Stanley maintained Equal Weight rating, Stifel lifted target price from $90 to $107, and TD Cowen stuck to its Hold rating for a company (implied to be Elastic).
2 reports, 1 independent
Updated Aug 31
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley maintained Equal Weight rating, Stifel lifted target price from $90 to $107, and TD Cowen stuck to its Hold rating for a company (implied to be Elastic).
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Morgan Stanley
U.S. investment bank
-
Stifel
American investment bank
-
TD Cowen
American investment bank
Related events
- Morgan Stanley restated its rating and target price, while TD Cowen lifted its target price on Twilio shares.
- Multiple financial firms (Barclays, UBS, Morgan Stanley, Jefferies) issued rating and price target updates for Equity Lifestyle Properties.
- Truist Financial set a $90.00 price target on Edwards Lifesciences shares, and TD Cowen reaffirmed its buy rating and raised the price objective.
- Citigroup, Morgan Stanley, and TD Cowen have raised their price targets and upgraded ratings for Royalty Pharma, with filings made public via the SEC.
- TD Cowen, Royal Bank of Canada, and Morgan Stanley all raised price targets and ratings for Ralliant.